Dr. Mary Maluccio is a Professor of Surgery and the new medical director of New Orleans Louisiana Neuroendocrine Tumor Specialists program, a strategic partnership between Louisiana State University and Ochsner Medical Center - Kenner.She received her medical degree from Columbia University College of Physicians and Surgeons. She did her internship and residency at New York Presbyterian Hospital, which she spent three years in an NIH research fellowship. She completed her surgical oncology fellowship at Memorial Sloan Kettering Cancer Center, which included a year focused on hepatobiliary surgical oncology. She's been interviewed and has received several clinical and research awards for her dedication to marginalized patient groups. Dr. Maluccio runs a research lab that's focused on primary and secondary cancers of the liver. This includes a continuum of efforts of basic science projects evaluating mechanism of inflammatory induced cancers, translational research projects investigating biomarkers of cancer in unique patient groups, bloodwork markers of response to surgical and nonsurgical cancer treatment as well as outcomes projects evaluating value-based treatment paradigms for cancer, which includes decision analysis modeling and cost analysis. Dr. Maluccio is grateful for the opportunity to take over the helm of the NOLANETS program. She brings a unique perspective to the neuroendocrine program having built a multidisciplinary effort in Indiana that cared for NET patients being evaluated for single or multi-visceral organ transplantation. This blossomed into a center of excellence in neuroendocrine within the MidWest region. She brings new energy to the program with her primary goal to marry what has historically been the most aggressive managerial approach to NET patients with emerging therapies that will define evidence-based treatment guidelines that optimize outcomes for patients. Dr. Maluccio specializes in Surgical Oncology, Cancer Surgery, Pancreatic cancer/ pancreas surgery, GIST, Gastrointestinal Stromal Surgery, Stomach cancer, stomach surgery, Hepato-biliary Surgery, Pancreatic Biliary Surgery, Metastatic Colo-rectal, liver surgery, Abdominal Surgery and Whipple procedure, Minimally invasive surgery, Nano Knife, Ablation.To learn more about the Neuroendocrine Tumor Program, click here.